Giddings Pharmaceutical Company is a maker of drugs for high
blood pressure and uses a process costing system. The following
information pertains to the final department of Giddings's
blockbuster drug called Solcax.
Beginning work-in-process (40% completed) | 800 | units | |
Transferred-in | 4,000 | units | |
Normal spoilage | 400 | units | |
Abnormal spoilage | 200 | units | |
Good units transferred out | 3,600 | units | |
Ending work-in-process (1/3 completed) | 600 | units | |
Conversion costs in beginning inventory | $ | 2,560 | |
Current conversion costs | $ | 6,900 | |
Giddings calculates separate costs of spoilage by computing both
normal and abnormal spoiled units. Normal spoilage costs are
reallocated to good units and abnormal spoilage costs are charged
as a loss. The units of Solcax that are spoiled are the result of
defects not discovered before inspection of finished units.
Materials are added at the beginning of the process. Using the
weighted-average method, answer the following question:
What are the total conversion costs in ending inventory?
$500.
$850.
$430.
$1,150.
Answer :
Get Answers For Free
Most questions answered within 1 hours.